Finance

Lists
SNOA:NASDAQ
Sonoma Pharmaceuticals Inc
1,23ย US$
+0,82%
(+0,0100) 1D
1,20ย US$
-2,44% (-0,030)
After hours
Closed: 6 แƒแƒฅแƒข, 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SNOA...
Open
1,27ย US$
High
1,27ย US$
Low
1,21ย US$
Mkt. cap
5,99ย แƒ›แƒšแƒœ.
Avg. vol.
52,06ย แƒแƒ—.
Volume
45,09ย แƒแƒ—.
52-wk high
4,45ย US$
52-wk low
0,85ย US$
EPS
-1,22ย US$
Beta
1,30
Shares outstanding
4,79ย แƒ›แƒšแƒœ.
No. of employees
260
Open
1,27ย US$
High
1,27ย US$
Low
1,21ย US$
Mkt. cap
5,99ย แƒ›แƒšแƒœ.
Avg. vol.
52,06ย แƒแƒ—.
Volume
45,09ย แƒแƒ—.
52-wk high
4,45ย US$
52-wk low
0,85ย US$
EPS
-1,22ย US$
Beta
1,30
Shares outstanding
4,79ย แƒ›แƒšแƒœ.
No. of employees
260
News stories
From web sources and news partners
TipRanks
TipRanks
·
4 แƒกแƒแƒแƒ—แƒ˜แƒก แƒฌแƒ˜แƒœ
Sonoma Pharmaceuticals Adopts New Tax-Protection Rights Plan
About Sonoma Pharmaceuticals Inc
CEO-
Employees260
Founded1999
Headquartersแƒ‘แƒแƒฃแƒšแƒ“แƒ”แƒ แƒ˜, แƒ™แƒแƒšแƒแƒ แƒแƒ“แƒแƒก แƒจแƒขแƒแƒขแƒ˜, แƒแƒ›แƒ”แƒ แƒ˜แƒ™แƒ˜แƒก แƒจแƒ”แƒ”แƒ แƒ—แƒ”แƒ‘แƒฃแƒšแƒ˜ แƒจแƒขแƒแƒขแƒ”แƒ‘แƒ˜
SectorPharmaceutical industry
Websitesonomapharma.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
แƒกแƒ”แƒฅ. 2025
แƒ“แƒ”แƒ™. 2025
แƒ›แƒแƒ . 2026
แƒ˜แƒ•แƒœ. 2026
Revenue
5,60ย แƒ›แƒšแƒœ.
4,35ย แƒ›แƒšแƒœ.
5,56ย แƒ›แƒšแƒœ.
6,41ย แƒ›แƒšแƒœ.
Cost of goods sold
3,48ย แƒ›แƒšแƒœ.
2,70ย แƒ›แƒšแƒœ.
3,38ย แƒ›แƒšแƒœ.
3,83ย แƒ›แƒšแƒœ.
Cost of revenue
3,48ย แƒ›แƒšแƒœ.
2,70ย แƒ›แƒšแƒœ.
3,38ย แƒ›แƒšแƒœ.
3,83ย แƒ›แƒšแƒœ.
Research and development expenses
575,00ย แƒแƒ—.
557,00ย แƒแƒ—.
545,00ย แƒแƒ—.
597,00ย แƒแƒ—.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,88ย แƒ›แƒšแƒœ.
1,77ย แƒ›แƒšแƒœ.
1,99ย แƒ›แƒšแƒœ.
2,02ย แƒ›แƒšแƒœ.
Operating expense
2,46ย แƒ›แƒšแƒœ.
2,33ย แƒ›แƒšแƒœ.
2,53ย แƒ›แƒšแƒœ.
2,62ย แƒ›แƒšแƒœ.
Total operating expenses
5,94ย แƒ›แƒšแƒœ.
5,03ย แƒ›แƒšแƒœ.
5,91ย แƒ›แƒšแƒœ.
6,45ย แƒ›แƒšแƒœ.
Operating income
-337,00ย แƒแƒ—.
-678,00ย แƒแƒ—.
-351,00ย แƒแƒ—.
-40,00ย แƒแƒ—.
Other non operating income
-394,00ย แƒแƒ—.
-271,00ย แƒแƒ—.
-1,59ย แƒ›แƒšแƒœ.
-
EBT including unusual items
-731,00ย แƒแƒ—.
-949,00ย แƒแƒ—.
-497,00ย แƒแƒ—.
-330,00ย แƒแƒ—.
EBT excluding unusual items
-731,00ย แƒแƒ—.
-949,00ย แƒแƒ—.
-497,00ย แƒแƒ—.
-330,00ย แƒแƒ—.
Income tax expense
-197,00ย แƒแƒ—.
-130,00ย แƒแƒ—.
84,00ย แƒแƒ—.
-
Effective tax rate
26,95%
13,70%
-16,90%
-
Other operating expenses
-
-
-
-
Net income
-534,00ย แƒแƒ—.
-819,00ย แƒแƒ—.
-581,00ย แƒแƒ—.
-330,00ย แƒแƒ—.
Net profit margin
-9,53%
-18,83%
-10,45%
-5,15%
Earnings per share
-
-0,48
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-301,00ย แƒแƒ—.
-644,00ย แƒแƒ—.
-318,00ย แƒแƒ—.
-8,00ย แƒแƒ—.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google แƒแƒžแƒ”แƒ‘แƒ˜